The DGDA had earlier approved the import of the vaccine for emergency use to cut short the time needed to bring the vaccines, he clarified. It analysed the data from clinical trials to determine whether to register the vaccine or give emergency use authorisation. Beximco Pharma, the sole distributor of the vaccine in Bangladesh, submitted on Dec 31 the documents required for permission to import the vaccine from India. Bangladesh has a deal with Serum Institute of India for 30 million doses of the Oxford-AstraZeneca vaccine. Hopes for Bangladesh receiving the vaccine doses soon were boosted after India’s regulators approved the emergency use of the vaccine on Sunday.

Source: bd News24 January 07, 2021 19:04 UTC